LY3844583

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3844583, covering 2024-05-10 to 2024-05-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis [Phase 1]